Suppr超能文献

胸放疗后 F 正电子发射断层扫描的心脏代谢变化可预测食管癌患者的总生存。

Cardiac metabolic changes on F-positron emission tomography after thoracic radiotherapy predict for overall survival in esophageal cancer patients.

机构信息

Department of Radiation Oncology, University of Washington, Seattle, Washington, USA.

Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA.

出版信息

J Appl Clin Med Phys. 2023 Sep;24(9):e13552. doi: 10.1002/acm2.13552. Epub 2022 Mar 4.

Abstract

PURPOSE

Heart doses have been shown to be predictive of cardiac toxicity and overall survival (OS) for esophageal cancer patients. There is potential for functional imaging to provide valuable cardiac information. The purpose of this study was to evaluate the cardiac metabolic dose-response using F-deoxyglucose (FDG)-PET and to assess whether standard uptake value (SUV) changes in the heart were predictive of OS.

METHODS

Fifty-one patients with esophageal cancer treated with radiation who underwent pre- and post-treatment FDG-PET scans were retrospectively evaluated. Pre- and post-treatment PET-scans were rigidly registered to the planning CT for each patient. Pre-treatment to post-treatment absolute mean SUV (SUVmean) changes in the heart were calculated to assess dose-response. A dose-response curve was generated by binning each voxel in the heart into 10 Gy dose-bins and analyzing the SUVmean changes in each dose-bin. Multivariate cox proportional hazard models were used to assess whether pre-to-post treatment cardiac SUVmean changes predicted for OS.

RESULTS

The cardiac dose-response curve demonstrated a trend of increasing cardiac SUV changes as a function of dose with an average increase of 0.044 SUV for every 10 Gy dose bin. In multivariate analysis, disease stage and SUVmean change in the heart were predictive (p < 0.05) for OS.

CONCLUSIONS

Changes in pre- to post-treatment cardiac SUV were predictive of OS with patients having a higher pre- to post-treatment cardiac SUV change surviving longer.

摘要

目的

心脏剂量已被证明可预测食管癌患者的心脏毒性和总生存期(OS)。功能成像有可能提供有价值的心脏信息。本研究旨在评估使用 F-脱氧葡萄糖(FDG)-PET 的心脏代谢剂量反应,并评估心脏的标准摄取值(SUV)变化是否可预测 OS。

方法

回顾性评估了 51 名接受放射治疗的食管癌患者,这些患者在治疗前后均进行了 FDG-PET 扫描。对每位患者的治疗前后 PET 扫描进行了刚性注册,以与计划 CT 进行配准。计算心脏的治疗前后绝对平均 SUV(SUVmean)变化,以评估剂量反应。通过将心脏中的每个体素分为 10 Gy 剂量区,并分析每个剂量区的 SUVmean 变化,生成剂量反应曲线。多变量 Cox 比例风险模型用于评估治疗前后心脏 SUVmean 变化是否可预测 OS。

结果

心脏剂量反应曲线显示出随着剂量增加而心脏 SUV 变化增加的趋势,每个 10 Gy 剂量区的平均 SUV 增加了 0.044。在多变量分析中,疾病分期和心脏 SUVmean 变化是 OS 的预测因素(p < 0.05)。

结论

治疗前后心脏 SUV 的变化可预测 OS,心脏 SUV 变化较大的患者生存期较长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1805/10476995/b631126625e2/ACM2-24-e13552-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验